Learn / ANRO
NYSE: ANRO
Alto Neuroscience (ANRO) stock, explained like you're 5
Alto Neuroscience trades on the New York Stock Exchange under the ticker ANRO. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 956 million dollars.
- Ticker
- ANRO
- Exchange
- New York Stock Exchange
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Size
- Small cap, about 956 million dollars
Is Alto Neuroscience a small, medium or large cap company?
No. Alto Neuroscience is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 956 million dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Alto Neuroscience makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves ANRO stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- Here's Why You Should Add ANRO Stock to Your Portfolio Now (Yahoo Finance)
- Alto Neuroscience: Doubts Around Depression Candidate Merit Downgrade To Hold (NYSE:ANRO) (Seeking Alpha)
- Here's Why You Should Add ANRO Stock to Your Portfolio Now (Zacks Investment Research)
- ANRO Stock Falls After Hours On Failed Schizophrenia Study Results (Stocktwits)
- Alto Neuroscience Inc. Stock Grades | ANRO (Barron's)
Follow ANRO in your daily brief
Each trading day at 5 PM ET we post what happened to Alto Neuroscience and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow ANRO
Questions about Alto Neuroscience stock
What does Alto Neuroscience do?
Alto Neuroscience trades on the New York Stock Exchange under the ticker ANRO. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 956 million dollars.
What is the ticker symbol for Alto Neuroscience?
Alto Neuroscience trades under the ticker ANRO on the New York Stock Exchange.
What is Alto Neuroscience's market cap?
Alto Neuroscience is a small cap stock with a market cap of about 956 million dollars.
How does Alto Neuroscience make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves ANRO stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow ANRO stock every day?
Add ANRO to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.